FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 5, 2014, Pages 739-746

  Kunne, Cindy ^a   Acco, Alexandra ^a,b   Duijst, Suzanne ^a   De Waart, Dirk R ^a   Paulusma, Coen C ^a   Gaemers, Ingrid ^a   Oude Elferink, Ronald P J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bile acid; CYP450 reductase; Fatty liver; FXR; Hrn

Indexed keywords

BILE SALT; CHOLIC ACID; CYTOCHROME P450 REDUCTASE; OBETICHOLIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; LIPID METABOLISM; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

BILE ACID; CYP450-REDUCTASE; FATTY LIVER; FXR; HRN;

ACETYL-COA CARBOXYLASE; ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL, VLDL; CHOLIC ACIDS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SCAVENGER RECEPTORS, CLASS B;

EID: 84896867418     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.02.004     Document Type: Article

References (29)

1. Chiang J.Y. Bile acids: regulation of synthesis. J. Lipid Res. 2009, 50:1955-1966.
2. Claudel T., Staels B., Kuipers F. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2020-2030.
3. Erickson S.K., Lear S.R., Deane S., Dubrac S., Huling S.L., Nguyen L., Bollineni J.S., Shefer S., Hyogo H., Cohen D.E., Shneider B., Sehayek E., Ananthanarayanan M., Balasubramaniyan N., Suchy F.J., Batta A.K., Salen G. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J. Lipid Res. 2003, 44:1001-1009.
4. Finn R.D., McLaren A.W., Carrie D., Henderson C.J., Wolf C.R. Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system. J. Pharmacol. Exp. Ther. 2007, 322:40-47.
5. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 2000, 6:517-526.
6. Henderson C.J., Otto D.M., Carrie D., Magnuson M.A., McLaren A.W., Rosewell I., Wolf C.R. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem. 2003, 278:13480-13486.
7. Hylemon P.B., Zhou H., Pandak W.M., Ren S., Gil G., Dent P. Bile acids as regulatory molecules. J. Lipid Res. 2009, 50:1509-1520.
8. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., Luo G., Jones S.A., Goodwin B., Richardson J.A., Gerard R.D., Repa J.J., Mangelsdorf D.J., Kliewer S.A. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005, 2:217-225.
9. Ishibashi S., Schwarz M., Frykman P.K., Herz J., Russell D.W. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J. Biol. Chem. 1996, 271:18017-18023.
10. Kerr T.A., Saeki S., Schneider M., Schaefer K., Berdy S., Redder T., Shan B., Russell D.W., Schwarz M. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev. Cell 2002, 2:713-720.
11. Kunne C., Acco A., Hohenester S., Duijst S., de Waart D.R., Zamanbin A., Elferink R.P. Defective bile salt biosynthesis and hydroxylation in mice with reduced cytochrome P450 activity. Hepatology 2013, 57:1509-1517.
12. Lee Y.K., Moore D.D. Liver receptor homolog-1, an emerging metabolic modulator. Front. Biosci. 2008, 13:5950-5958.
13. Li T., Francl J.M., Boehme S., Chiang J.Y. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7alpha-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice. Hepatology 2013, 58:1111-1121.
14. Lu T.T., Makishima M., Repa J.J., Schoonjans K., Kerr T.A., Auwerx J., Mangelsdorf D.J. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 2000, 6:507-515.
15. Shen L.L., Liu H., Peng J., Gan L., Lu L., Zhang Q., Li L., He F., Jiang Y. Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase. Mol Biol Rep 2011, 38:553-559.
16. Matsukuma K.E., Bennett M.K., Huang J., Wang L., Gil G., Osborne T.F. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase. J. Lipid Res. 2006, 47:2754-2761.
17. Miyata M., Sakaida Y., Matsuzawa H., Yoshinari K., Yamazoe Y. Fibroblast growth factor 19 treatment ameliorates disruption of hepatic lipid metabolism in farnesoid X receptor (Fxr)-null mice. Biol. Pharm. Bull. 2011, 34:1885-1889.
18. Mutch D.M., Klocke B., Morrison P., Murray C.A., Henderson C.J., Seifert M., Williamson G. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism. J. Proteome Res. 2007, 6:3976-3984.
19. Kumar Srivastava Niraj, Pradhan Sunil, Mittal Balraj, Kumar Raj, Nagana Gowda G.A. An improved, single step standardized method of lipid extraction from human skeletal muscle tissue. Anal. Lett. 2012, 39:297-315.
20. Pineda T., Claudel T., Duval C., Kosykh V., Fruchart J.C., Staels B. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol. Endocrinol. 2003, 17:259-272.
21. Ruijter J.M., Pfaffl M.W., Zhao S., Spiess A.N., Boggy G., Blom J., Rutledge R.G., Sisti D., Lievens A., De P.K., Derveaux S., Hellemans J., Vandesompele J. Evaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implications. Methods 2013, 59:32-46.
22. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
23. Sambrook J., Fritish E.F., Manniatis T. Molecular Cloning: A Laboratory Manual, Section 15 1989, 1847-1876. Cold Spring Harbor, New York.
24. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744.
25. Thomas C., Auwerx J., Schoonjans K. Bile acids and the membrane bile acid receptor TGR5-connecting nutrition and metabolism. Thyroid 2008, 18:167-174.
26. Thomas C., Pellicciari R., Pruzanski M., Auwerx J., Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat. Rev. Drug Discov. 2008, 7:678-693.
27. Wang L., Lee Y.K., Bundman D., Han Y., Thevananther S., Kim C.S., Chua S.S., Wei P., Heyman R.A., Karin M., Moore D.D. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell 2002, 2:721-731.
28. Watanabe M., Houten S.M., Wang L., Moschetta A., Mangelsdorf D.J., Heyman R.A., Moore D.D., Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest. 2004, 113:1408-1418.
29. Zhang Y., Castellani L.W., Sinal C.J., Gonzalez F.J., Edwards P.A. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 2004, 18:157-169.